Medtronic Gross Margin 2010-2025 | MDT
Medtronic Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2025-01-31 | $33.20B | $21.67B | 65.27% |
2024-10-31 | $33.00B | $21.46B | 65.04% |
2024-07-31 | $32.58B | $21.23B | 65.16% |
2024-04-30 | $32.36B | $21.15B | 65.34% |
2024-01-31 | $32.32B | $21.17B | 65.50% |
2023-10-31 | $31.96B | $20.90B | 65.40% |
2023-07-31 | $31.56B | $20.73B | 65.68% |
2023-04-30 | $31.23B | $20.51B | 65.67% |
2023-01-31 | $30.77B | $20.44B | 66.43% |
2022-10-31 | $30.81B | $20.71B | 67.21% |
2022-07-31 | $31.07B | $21.01B | 67.61% |
2022-04-30 | $31.69B | $21.54B | 67.98% |
2022-01-31 | $31.79B | $21.58B | 67.89% |
2021-10-31 | $31.80B | $21.43B | 67.39% |
2021-07-31 | $31.60B | $21.02B | 66.53% |
2021-04-30 | $30.12B | $19.63B | 65.19% |
2021-01-31 | $27.93B | $17.83B | 63.85% |
2020-10-31 | $27.87B | $17.99B | 64.57% |
2020-07-31 | $27.93B | $18.36B | 65.76% |
2020-04-30 | $28.91B | $19.49B | 67.41% |
2020-01-31 | $31.06B | $21.42B | 68.96% |
2019-10-31 | $30.89B | $21.38B | 69.22% |
2019-07-31 | $30.67B | $21.35B | 69.62% |
2019-04-30 | $30.56B | $21.40B | 70.04% |
2019-01-31 | $30.56B | $21.49B | 70.32% |
2018-10-31 | $30.38B | $21.38B | 70.38% |
2018-07-31 | $29.95B | $21.03B | 70.22% |
2018-04-30 | $29.95B | $20.89B | 69.73% |
2018-01-31 | $29.73B | $20.62B | 69.36% |
2017-10-31 | $29.64B | $20.46B | 69.02% |
2017-07-31 | $29.93B | $20.55B | 68.65% |
2017-04-30 | $29.71B | $20.42B | 68.72% |
2017-01-31 | $29.36B | $20.14B | 68.60% |
2016-10-31 | $29.01B | $19.92B | 68.66% |
2016-07-31 | $28.73B | $19.78B | 68.85% |
2016-04-30 | $28.83B | $19.69B | 68.29% |
2016-01-31 | $28.57B | $18.86B | 66.00% |
2015-10-31 | $25.95B | $17.25B | 66.48% |
2015-07-31 | $23.26B | $15.60B | 67.07% |
2015-04-30 | $20.26B | $13.95B | 68.86% |
2015-01-31 | $17.52B | $12.98B | 74.06% |
2014-10-31 | $17.37B | $12.90B | 74.27% |
2014-07-31 | $17.20B | $12.78B | 74.32% |
2014-04-30 | $17.01B | $12.67B | 74.52% |
2014-01-31 | $16.90B | $12.60B | 74.58% |
2013-10-31 | $16.76B | $12.52B | 74.68% |
2013-07-31 | $16.67B | $12.49B | 74.95% |
2013-04-30 | $16.59B | $12.46B | 75.13% |
2013-01-31 | $16.43B | $12.39B | 75.41% |
2012-10-31 | $16.32B | $12.35B | 75.66% |
2012-07-31 | $16.25B | $12.34B | 75.93% |
2012-04-30 | $16.18B | $12.30B | 75.97% |
2012-01-31 | $15.86B | $12.11B | 76.33% |
2011-10-31 | $15.80B | $12.04B | 76.22% |
2011-07-31 | $15.68B | $11.92B | 76.03% |
2011-04-30 | $15.51B | $11.81B | 76.14% |
2011-01-31 | $15.30B | $11.73B | 76.67% |
2010-10-31 | $15.30B | $11.75B | 76.81% |
2010-07-31 | $15.23B | $11.72B | 76.96% |
2010-04-30 | $15.39B | $11.81B | 76.73% |
2010-01-31 | $15.45B | $11.72B | 75.85% |
2009-10-31 | $15.09B | $11.43B | 75.70% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $115.624B | $32.364B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
Boston Scientific (BSX) | United States | $154.056B | 41.59 |
Stryker (SYK) | United States | $148.022B | 31.82 |
EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
Agilent Technologies (A) | United States | $38.594B | 25.57 |
ResMed (RMD) | United States | $33.728B | 25.98 |
Terumo (TRUMY) | Japan | $25.984B | 36.95 |
Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
Insulet (PODD) | United States | $19.908B | 85.13 |
Baxter (BAX) | United States | $17.948B | 12.94 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
Demant (WILYY) | Denmark | $8.092B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
ICU Medical (ICUI) | United States | $3.924B | 37.35 |
Envista Holdings (NVST) | United States | $3.683B | 29.30 |
Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
Haemonetics (HAE) | United States | $3.312B | 15.58 |
Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
Neogen (NEOG) | United States | $2.261B | 26.05 |
AtriCure (ATRC) | United States | $1.916B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
InMode (INMD) | Israel | $1.330B | 11.12 |
BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
CeriBell (CBLL) | United States | $0.911B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
Evolus (EOLS) | United States | $0.893B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
Valneva SE (VALN) | France | $0.635B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
Omeros (OMER) | United States | $0.503B | 0.00 |
Surmodics (SRDX) | United States | $0.501B | 0.00 |
Owens & Minor (OMI) | United States | $0.493B | 3.85 |
SNDL (SNDL) | Canada | $0.439B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
ZimVie (ZIMV) | United States | $0.368B | 30.98 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
Quanterix (QTRX) | United States | $0.311B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
Cerus (CERS) | United States | $0.305B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
Biote (BTMD) | United States | $0.252B | 5.52 |
Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
Zynex (ZYXI) | United States | $0.234B | 49.07 |
Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
High Tide (HITI) | Canada | $0.205B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
Brainsway (BWAY) | Israel | $0.184B | 97.80 |
TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
MacroGenics (MGNX) | United States | $0.166B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
Jin Medical (ZJYL) | China | $0.114B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
Fonar (FONR) | United States | $0.092B | 12.92 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Veru (VERU) | United States | $0.083B | 0.00 |
InterCure (INCR) | Israel | $0.076B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
Exagen (XGN) | United States | $0.063B | 0.00 |
Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
Apyx Medical (APYX) | United States | $0.054B | 0.00 |
Hongchang (HCIL) | China | $0.051B | 0.00 |
United-Guardian (UG) | United States | $0.046B | 13.24 |
ImmuCell (ICCC) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
INLIF (INLF) | $0.032B | 0.00 | |
Safety Shot (SHOT) | United States | $0.028B | 0.00 |
Nephros (NEPH) | United States | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |